ALEC

Conviction 28HealthcareScan · Mon, Aug 10, 2026

ALEC$1.68-5.62%

ResistanceSupportVol 14Insider sell

Vol MA14 1.04M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Alector, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.alector.com ↗

Price1.68

Change-5.62%

Gap-1.12%

Rel volume4.22×

Avg volume897.27K

Avg $ vol1.49M

SMA 201.54

SMA 501.68

SMA 2001.84

Price vs 50-0.22%

Price vs 200-8.52%

MA stackbearish

50/200 cross—

Supertrenddown · 1.84

RSI (14)52

MACD hist0.04

MACD crossbull · 9d

Stoch %K / %D39 / 55

ADX (14)21

+DI / −DI30 / 19

RSI divergence—

MACD divergence—

ATR %+9.49%

ADR %8.60%

52w high3.32

52w low1.14

From 52w high-49.40%

Above 52w low+47.37%

New 52w highNo

SqueezeOff

Bollinger width27.36%

%B0.83

Donchian pos46.62%

Donchian high2.04

Donchian low1.37

AVWAP (52w high)1.74

vs AVWAP high-3.31%

AVWAP (52w low)1.85

vs AVWAP low-9.22%

OBV trendFlat

Chaikin MF (20)0.04

Today vs 20d4.22×

Avg vol (14d)1.04M

Avg vol (20d)897.27K

Avg $ vol (20d)1.49M

Market cap187.58M

RS 3m (vs SPY)-32.75%

RS 6m (vs SPY)-16.31%

RS line new highNo

Trend template2/8

Technical rank37.9

1 week+11.26%

1 month+4.35%

3 months-20.00%

6 months-14.29%

1 year+15.07%

YTD+9.80%

P/E-1.31

P/B-18.81

P/S8.91

P/FCF-1.02

EPS-1.39

Div yield—

ROE—

ROA-70.46%

Debt/Eq-0.99

Current5.26

EV/EBITDA-0.92

Gross margin—

Net margin-679.16%

Rev growth-79.07%

EPS growth-20.06%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value137.52M

Revenue3.32M

Net income-22.99M

Gross profit—

Free cash flow-184.07M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out111.03M

Employees103

ListedThu, Feb 7, 2019

Free float82.98M

Float %76.0%

Short interest5.66M

Days to cover10.2d

Short volume38.3%

Squeeze score54 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction28 / 100

Pattern quality—

Tech rank37.9 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.09

Support1.37

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ALEC

All disclosures →

No recent disclosed trades by Congress in ALEC. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ALEC · 10 buys

Insider	Side	Shares	Value	Traded	Filed
Wong-Sarad Grace Principal Accounting Officer · Common Stock · 2026-07-09	Grant	20K	—	2026-07-09	2026-07-09
SCHELLER RICHARD H Director · Stock Option (right to buy) · 2026-06-17	Grant	9.45K	—	2026-06-17	2026-06-17
GAROFALO ELIZABETH A. Director · Stock Option (right to buy) · 2026-06-17	Grant	9.45K	—	2026-06-17	2026-06-17
Yaffe Kristine Director · Stock Option (right to buy) · 2026-06-17	Grant	9.45K	—	2026-06-17	2026-06-17
LAVIGNE LOUIS J JR Director · Common Stock · 2026-06-17	Grant	28.7K	—	2026-06-17	2026-06-17
LAVIGNE LOUIS J JR Director · Stock Option (right to buy) · 2026-06-17	Grant	9.45K	—	2026-06-17	2026-06-17
DESOUZA ERROL B Director · Common Stock · 2026-06-17	Grant	28.7K	—	2026-06-17	2026-06-17
DESOUZA ERROL B Director · Stock Option (right to buy) · 2026-06-17	Grant	9.45K	—	2026-06-17	2026-06-17
Altmeyer Mark Director · Common Stock · 2026-06-17	Grant	28.7K	—	2026-06-17	2026-06-17
Altmeyer Mark Director · Stock Option (right to buy) · 2026-06-17	Grant	9.45K	—	2026-06-17	2026-06-17

SEC filings

EDGAR filings in ALEC · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.